South London + Maudsley NHS Foundation Trust
Information Governance Office
Maudsley Hospital
Denmark Hill
London
SE5 8AZ
Email: foi@slam.nhs.uk
23 August 2021
Dear Ms Micklewright,
RE: Your Information Request
Thank you for your request for information received on 25 April 2021 regarding ECT, serious incidents, restraints, seclusions and medication errors, under the terms of the Freedom of Information Act (2000).
You requested the following information:
Maudsley Hospital
Denmark Hill
London
SE5 8AZ
Email: foi@slam.nhs.uk
23 August 2021
Dear Ms Micklewright,
RE: Your Information Request
Thank you for your request for information received on 25 April 2021 regarding ECT, serious incidents, restraints, seclusions and medication errors, under the terms of the Freedom of Information Act (2000).
You requested the following information:
ECT Information
Please supply patient’s information ECT leaflet.
Please see attached pdf document titled ‘Patient Information Leaflet’.
Please supply patient ECT consent form.
Please see attached pdf document titled ‘Patient Agreement to ECT - Consent Form 1’.
Please supply any ECT reports / investigations.
Please be advised that this information is withheld under s.40 of the FOIA (Personal Information) as it contains personal data other than personal data of the requester, and where disclosure under the Act would breach one of the data protection principles in the General Data Protection Regulation (GDPR) or Data Protection Act 2018 (DPA). It is our view that disclosing this information would breach the fair processing provisions of the first data protection principle, in that it would not be the reasonable expectation of these individuals that their personal data would be disclosed in this way. The exemption at section 40 is an absolute exemption and does not require consideration of the public interest test.
How many ECT in 2020 / 2021
The Trust carried out 341 ECT’s in 2020 / 2021.
What proportion of patients were men/women.
Please see table below:
Gender | Total |
Male | 22 |
Female | 32 |
How old were they?
Please see table below:
Gender | Age Range |
Male | 22 - 84 |
Female | 20 - 79 |
What proportion of patients were classified BAME?
Please see table below:
Gender | Age Range |
Male | 7 |
Female | 13 |
How many were receiving ECT for the first time?
Please see table below:
Gender | Total |
Male | 13 |
Female | 14 |
How many patients consented to ECT?
Please see table below:
Gender | Total |
Male | 5 |
Female | 7 |
How many patients died during or 1 month after ECT and what was the cause (whether or not ECT was considered the cause).
None.
How many patients died at 6 months after ECT and what was the cause a (whether or not ECT was considered the cause).
None.
How many patients died by suicide within 6 months of receiving ECT (whether or notECT was considered the cause).
None.
How many patients have suffered complications during and after ECT and what were those complications?
None.
Have there been any formal complaints from patients/relatives about ECT?
None.
If so, what was their concern?
Not applicable.
How many patients report memory loss/loss of cognitive function?
About half of the patients complain about memory loss/cognitive function but this is very mild and sometimes does not last.
What tests are used to assess memory loss/loss of cognitive function?
Cognitive and memory tests are used to assess memory loss / cognitive function.
Have MRI or CT scans been used before and after ECT.
No.
If so, what was the conclusion?
Not applicable.
How does the Trust plan to prevent ECT in the future?
Electroconvulsive therapy (ECT) is the most efficacious treatment available for individuals with severe affective disorders. Although electroconvulsive therapy (ECT) is considered the most efficacious treatment available for individuals with severe affective disorders, ECT’s availability is limited and declining, suggesting that information about the population-level effects of ECT is needed. In the short-term treatment of a major depressive episode, the combination of ECT and pharmacotherapy as continuation treatment is more potent than either intervention alone. Unfortunately, ECT has been used in the UK mainly when antidepressants have not worked and the depression is severe. The rate of use in the UK is a sixth that in the US. Many people who have not responded to antidepressants or psychotherapy could benefit from ECT but do not get it.
Electroconvulsive therapy may be associated with reduced short-term psychiatric inpatient readmissions among psychiatric with severe affective disorders. This potential population health effect may be overlooked regarding the availability of ECT. Meaning electroconvulsive therapy may be an effective and cost-effective treatment for treatment-resistant depression and should be considered after failure of 2 or more lines of pharmacotherapy and/or psychotherapy. Offering ECT after 2 failed lines of pharmacotherapy/psychotherapy is most likely to maximise its health-economic value and is concordant with recommendations from some national guidelines and ECT specialists. The increasing use of ECT by offering it earlier in the course of treatment-resistant depression could significantly improve outcomes for this difficult-to-treat patient population.
Serious Incident Information
Please supply any serious incident reports/investigations
Independent investigation reports are confidential until published by NHS England and these can be accessed from their website https://www.england.nhs.uk/publications/reviewsandreports/invest-reports/
In addition, anonymised “lessons learned” reports are cascaded to relevant parties to ensure that improvements are delivered.
How many serious incident reports in 2020?
A total of 119 serious incident reports were recorded in 2020.
What proportion of patients were men/women?
Please see table below:
Men | Women |
82 | 37 |
How old were they?
The provision of the requested information would exceed the appropriate cost limit under Section 12, which is currently £450. This equates to 18 hours of staff time at £25 an hour. This is because the information requested is not easily retrievable as we do not hold this information in a readily accessible format. To locate and retrieve this information would require a manual search of all individual records. Under the FOIA, an authority is allowed to refuse a request where to comply with the request would exceed the appropriate cost limit.
What proportion of patients were classified BAME?
Please refer to the response to Q.4 above.
How many serious incident reports were investigated outside the NHS and CCG?
All Serious incidents are investigated by the NHS and CCGs. NHSE may commission an independent organisation for independent homicide reviews (but the investigation comes from NHSE)
How many patients died during or 1 month after serious incident reports and what was the cause (whether or not serious incident reports was considered the cause)?
Please refer to the response to Q.4 above.
How many patients died within 6 months after serious incident reports and what was the cause (whether or not serious incident reports was considered the cause)?
Please refer to the response to Q.4 above
How many patients died by suicide within 6 months of receiving serious incident reports ( whether or not serious incident reports was considered the cause)?
Please refer to the response to Q.4 above.
How many patients have suffered complications during and after serious incident reports andwhat were those complications?
Please refer to the response to Q.4 above.
Have there been any formal complaints from patients/relatives about serious incident reports?
Yes.
If so, what was their concerns?
The Trust is currently awaiting receipt of the report.
How does the Trust plan to prevent serious incidents in the future?
The purpose of the Serious Incident Investigation is to identify learning and therefore make improvements in clinical care and practice. The Trust has a number of committees in place to review and make recommendations and areas of good practice arising from Investigations are acted upon and disseminated across the Trust.
Restraints information
Please supply any Restraints / investigations.
Please be advised that this information is withheld under s.40 of the FOIA (Personal Information) as it contains personal data other than personal data of the requester, and where disclosure under the Act would breach one of the data protection principles in the General Data Protection Regulation (GDPR) or Data Protection Act 2018 (DPA). It is our view that disclosing this information would breach the fair processing provisions of the first data protection principle, in that it would not be the reasonable expectation of these individuals that their personal data would be disclosed in this way. The exemption at section 40 is an absolute exemption and does not require consideration of the public interest test.
How many restraints in 2020?
Please refer to the response to Q.1 above.
What proportion of patients were men/women?
Please refer to the response to Q.1 above.
How old were they?
Please refer to the response to Q.1 above.
What proportion of patients were classified BAME?
Please refer to the response to Q.1 above.
How many restraints were investigated outside the NHS and CCG?
Please refer to the response to Q.1 above.
How many patients died during or 1 month after restraints and what was the cause(whether or not restraints was considered the cause)?
Please refer to the response to Q.1 above.
How many patients died within 6 months after restraints and what was the cause(whether or not restraints was considered the cause)?
Please refer to the response to Q.1 above.
How many patients died by suicide within 6 months of receiving restraints (whether ornot restraints was considered the cause)?
Please refer to the response to Q.1 above.
How many patients have suffered complications during and after restraints and whatwere those complications?
Please refer to the response to Q.1 above.
Have there been any formal complaints from patients/relatives about restraints?
Between 01.04.2020 – 31.03.2021 there were 4 complaints regarding completed restraints
If so, what was their concerns?
A total of three complaints were made regarding what the complainant perceived as excessive force.
1 complaint was regarding restraint that did not take place: patients said they were not sure under what circumstances restraint would be used
Are counts of forced injections available?
Please refer to the response at Q1 above
How does the Trust plan to reduce restraints in the future?
The Trust has a multidisciplinary working group, including lived experience representative, which focuses on safety, including use of restraint and seclusion, in the Trust. The group employs a quality improvement methodology and other change methodologies to test, evaluate and then scale and spread improvement initiatives.
Seclusion Information
Please supply any seclusion reports/investigations
Please be advised that this information is withheld under s.40 of the FOIA (Personal
Information) as it contains personal data other than personal data of the requester, and where disclosure under the Act would breach one of the data protection principles in the General Data Protection Regulation (GDPR) or Data Protection Act 2018 (DPA). It is our view that disclosing this information would breach the fair processing provisions of the first data protection principle, in that it would not be the reasonable expectation of these individuals that their personal data would be disclosed in this way. The exemption at section 40 is an absolute exemption and does not require consideration of the public interest test.
How many seclusions in 2020?
A total of 654 seclusions were recorded in 2020.
What proportion of patients were men/women?
The provision of the requested information would exceed the appropriate cost limit under Section 12, which is currently £450. This equates to 18 hours of staff time at £25 an hour. This is because the information requested is not easily retrievable as we do not hold this information in a readily accessible format. To locate and retrieve this information would require a manual search of all individual records. Under the FOIA, an authority is allowed to refuse a request where to comply with the request would exceed the appropriate cost limit.
How old were they?
Please refer to the response to Q.3 above.
What proportion of patients were classified BAME?
Please be advised that, the provision of the requested information would exceed the appropriate cost limit under Section 12, which is currently £450. This equates to 18 hours of staff time at £25 an hour. This is because the information requested is not easily retrievable as we do not hold this information in a readily accessible format. To locate and retrieve this information would require a manual search of all individual records. Under the FOIA, an authority is allowed to refuse a request where to comply with the request would exceed the appropriate cost limit.
How many seclusions were investigated outside the NHS and CCG?
Not applicable.
How many patients died during or 1 month after seclusion and what was the cause(whether or not seclusion was considered the cause)?
Please refer to response to Q.5 above.
How many patients died within 6 months after seclusion and what was the cause (whetheror not seclusion was considered the cause)?
Please refer to response to Q.5 above.
How many patients died by suicide within 6 months of receiving seclusion (whether or notseclusion was considered the cause)?
Please refer to the response to Q.5 above.
How many patients have suffered complications during and after seclusion and whatwere those complications?
Please refer to the response to Q.5 above.
Have there been any formal complaints from patients/relatives about seclusion?
Yes.
If so, what was their concerns?
The complaints were related to care, treatment, attitude and behaviour.
How does the Trust plan to prevent seclusion in the future?
The Trust has a multidisciplinary working group, including lived experience representative, which focuses on safety, including use of restraint and seclusion, in the Trust. The group employs a quality improvement methodology and other change methodologies to test, evaluate and then scale and spread improvement initiatives.
Medication Errors Information
Please supply any medication errors reports/investigations
Please see the following enclosed documents:
- ‘Medicines safety committee minutes 14th January 2020 FINAL’
- ‘MSC minutes 11th June 2020 final’
- ‘MSC minutes 17th December 2020’
- ‘MSC minutes 30th September 2020’
- ‘DATIX reported medication incidents April to June 2020’
- ‘DATIX reported medication incidents January to March 2020’
- ‘DATIX reported medication incidents July to September 2020 (002)’
- ‘DATIX reported medication incidents October to December 2020’
How many medication errors in 2020?
There was a total of 2,301 medication incidents reported in 2020.
It is important to note that the figures provided are reported medication incidents. We are not able to provide information on errors only as it will require extensive resources to review all reported incidents to identify those that are solely medications errors.
Medication incidents include not only errors but other incidents such as loss of stationery (e.g. prescription charts, FP10 prescriptions), loss of drug cupboard keys, fridge breakdown and CD balance errors etc.. A significant part of the incidents may also be due to administration of medication under rapid tranquilisation where our policy states we have to document this as an incident.
What proportion of patients were men/women?
Please be advised that, the provision of the requested information would exceed the appropriate cost limit under Section 12, which is currently £450. This equates to 18 hours of staff time at £25 an hour. This is because the information requested is not easily retrievable as we do not hold this information in a readily accessible format. To locate and retrieve this information would require a manual search of all individual records. Under the FOIA, an authority is allowed to refuse a request where to comply with the request would exceed the appropriate cost limit.
How old were they?
Please refer to the response to Q.3 above.
What proportion of patients were classified BAME?
Please refer to the response to Q.3 above.
How many medication errors were investigated outside the NHS and CCG?
Please refer to the response to Q.3 above.
How many patients died during or 1 month after medication errors and what was thecause (whether or not medication errors was considered the cause)?
Please refer to the response to Q.3 above.
How many patients died within 6 months after medication errors and what was thecause (whether or not medication errors was considered the cause)?
Please refer to the response to Q.3 above.
How many patients died by suicide within 6 months of receiving medication errors(whether or not medication errors were considered the cause)?
Please refer to the response to Q.3 above
How many patients have suffered complications during and after medication errors andwhat were those complications?
Please refer to the response to Q.3 above.
Have there been any formal complaints from patients/relatives about medication errors?
Please refer to the response to Q.3 above
If so, what was their concerns?
Not applicable.
How does the Trust plan to prevent medication errors in the future?
The overall aim or purpose of the Medicines Safety Committee is to ensure the safe use of medicines in the trust
Key objectives:
▪ To review the medication section of the trust incident reporting policy
▪ To agree a process for improving the rate and quality of medication incident reporting in the trust
▪ To agree a system for follow-up of medication incidents
▪ To agree a system for disseminating learning points from commonly reported and serious medication incidents
▪ To recommend changes to medicines procedures where necessary
▪ To develop medicines procedures where necessary
▪ To inform the trust and other relevant stakeholders of risks identified from medication errors.
▪ To recommend ways of reducing the likelihood of serious errors recurring and developing ways of minimising risk from medication errors.
▪ To provide a summary of incidents in the annual medicines report to the trust board. This will include assurance to the trust board that medicines incidents are appropriately reported and that follow-up includes learning and a change in practice where necessary.
▪ To review the medication risks on the trust assurance log (risk register).
▪ To liaise with KHP partners when necessary in order to standardise practice and share learning across the trusts and CCGs.
▪ To advise on any changes in the medicines policy following complaints about medicines from patients and carers.
The committee meets four times a year.
The information supplied to you continues to be protected by the Copyright, Designs and Patents Act 1988. You are free to use it for your own purposes, including any non-commercial research you are doing and for the purposes of news reporting. Any other reuse, for example commercial publication, would require the permission of the Trust. This may be done by writing to the Information Governance Office at the above address.
If you have any queries about this letter or if you are unhappy with the service you have received in relation to your request and wish to make a complaint or request a review of our decision, please do not hesitate to contact the Information Governance Office via foi@slam.nhs.uk
If you are not content with the outcome of your complaint, you may apply to the Information Commissioner for a decision. Generally, the ICO cannot make a decision unless you have exhausted the complaints procedure provided by South London and Maudsley NHS Foundation Trust. The Information Commissioner can be contacted at:
The Information Commissioner’s Office
Wycliffe House
Water Lane
Wilmslow
Cheshire SK9 5AF
Yours sincerely,
Christopher Howarth
Christopher Howarth
Information Governance Assurance Manager